A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

NCT02692716 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3183

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: semaglutide
DRUG: placebo

Sponsor

Novo Nordisk A/S